Pharmacy Benefits in Focus: Reflections and Predictions
Expect another year of non-specialty drugs surpassing specialty drugs in their overall contributions to trend. GLP-1s will continue to be major drivers.
Expect another year of non-specialty drugs surpassing specialty drugs in their overall contributions to trend. GLP-1s will continue to be major drivers.
We are pleased to add Lexi Yonkovic to the National CooperativeRx team! As a strategic account executive, Lexi will build and maintain strong relationships with member groups …
As a sales and account associate, Zach supports our strategic account executives and clinical team in fostering relationships with existing members and partners.
Offering rebates has been a pricing strategy for manufacturers of brand-named prescription drugs for decades. The explosion of rebate value has happened over the last 10-12 years as pharmacy benefit managers (PBMs)
In this final part of the series, we will dive into PBM performance and support—answering questions about how PBMs gauge plan effectiveness and provide support to stakeholders.
At National CooperativeRx, the strength of our cooperative lies in the satisfaction of our members and partners. Their feedback shapes our services and drives our commitment to excellence.